James Woodruff Lillie, Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT), sold 51,707 shares at $27.50 ($1.5M) on 2026-05-04, disclosed to the SEC on 2026-05-06.
Scheduled sale ($1.5M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 9,250 | $254K | 17.3% |
| 2 | $28.37 | 5,526 | $157K | 10.7% |
| 3 | $29.56 | 320 | $9K | 0.6% |
| 4 | $30.08 | 705 | $21K | 1.4% |
| 5 | $28.12 | 10,132 | $285K | 19.4% |
| 6 | $29.00 | 963 |
| $28K |
| 1.9% |
| 7 | $28.04 | 8,390 | $235K | 16.0% |
| 8 | $29.13 | 16,421 | $478K | 32.6% |
| Total | $28.40 avg | 51,707 | $1.5M | 100% |
| Filing → |
| MPLT | SELL | 2026-05-11 | $20K | — | Filing → |
| MPLT | SELL | 2026-04-17 | $123K | — | Filing → |